Overall, these data suggest that GPER1 might play a potential tumor suppressor role, as demonstrated in other hematological malignancies such as AML, MCL, and WM, and therefore, its activation can trigger anti-tumor effects. Here, GPER1 is linked to mantle cell lymphoma.